Smith & Nephew plc logo
Smith & Nephew plc SNN
$ 28.87 0.63%
report update icon

Quarterly report 2025-Q4
added 05-06-2026

Smith & Nephew plc Balance Sheet 2025-2011 | SNN

Brief overview of Smith & Nephew plc's balance sheet structure

The review uses the five latest available annual reports between 2021 and 2025.

The asset base was stable: the change from $10.9 billion to $10.5 billion does not indicate a material increase in scale.

The growth rates were balanced: assets changed -4.2%, while liabilities changed -3.4%.

Equity accounts for 50.6% of assets. Against the initial , the capital position looks resilient.

The balance sheet holds more cash than interest-bearing debt; net debt is -$341 million, indicating minimal leverage.

Cash accounts for 5.3% of assets versus 11.8% initially. The change indicates the degree of financial flexibility.

Retained earnings are $5.3 billion versus initially. The direction shows how results contributed to equity.

Balance sheet takeaway

Smith & Nephew plc's financial position is positive on balance sheet evidence. Growth in resources has not undermined capital strength.

Annual Balance Sheet Smith & Nephew plc

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-341 M -423 M -103 M -154 M - 1.5 B 1.64 B 968 M 1.28 B 1.54 B 1.35 B 1.6 B 240 M 274 M 138 M

Long Term Debt

149 M 135 M 144 M 147 M - 3.2 B 1.85 B 1.3 B 1.42 B 1.56 B 1.43 B 1.66 B 335 M 416 M 16 M

Long Term Debt Current

67 M 61 M 55 M 49 M 56 M 58 M 46 M - - - - - - - -

Total Non Current Liabilities

3.57 B 3.56 B 2.5 B 2.99 B - 4.04 B 2.59 B 1.72 B 1.88 B 2.04 B 1.86 B 2.1 B 699 M 828 M 441 M

Total Liabilities

5.17 B 5.09 B 4.77 B 4.71 B 5.35 B 5.73 B 4.16 B 3.18 B 3.22 B 3.39 B 3.2 B 3.27 B 1.77 B 1.76 B 1.56 B

Retained Earnings

5.32 B 5.02 B 4.91 B 5.03 B - 4.96 B 4.85 B 4.62 B 4.33 B 3.97 B 3.73 B 3.65 B 3.52 B 3.82 B 3.26 B

Total Assets

10.5 B 10.4 B 9.99 B 9.97 B 10.9 B 11 B 9.3 B 8.06 B 7.87 B 7.34 B 7.17 B 7.31 B 5.82 B 5.64 B 4.75 B

Cash and Cash Equivalents

557 M 619 M 302 M 350 M 1.28 B 1.75 B 257 M 333 M 155 M 38 M 102 M - - - -

Book Value

5.29 B 5.26 B 5.22 B 5.26 B 5.57 B 5.28 B 5.14 B 4.87 B 4.64 B 3.96 B 3.97 B 4.04 B 4.05 B 3.88 B 3.19 B

Total Shareholders Equity

5.29 B 5.26 B 5.22 B 5.26 B - 5.28 B 5.14 B 4.87 B 4.64 B 3.96 B 3.97 B - - - -

All numbers in USD currency

Quarterly Balance Sheet Smith & Nephew plc

2025-Q4 2024-Q4 2023-Q4 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

149 M 135 M 144 M - - - - 141 M - - - 146 M - - - 124 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

3.57 B 3.56 B 2.5 B - - - - 3.22 B - - - 4.04 B - - - 2.59 B - - - 1.72 B - - - 1.88 B - - - 2.04 B - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

5.17 B 5.09 B 4.77 B - - - - 5.35 B - - - 5.73 B - - - 4.16 B - - - 3.18 B - - - 3.22 B - - - 3.39 B - - - 3.2 B - - - - - - - - - - - - - - - - - - -

Retained Earnings

5.32 B 5.02 B 4.91 B - - - - 5.22 B - - - 4.96 B - - - 4.85 B - - - 4.62 B - - - 4.33 B - - - 3.97 B - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

10.5 B 10.4 B 9.99 B - - - - 10.9 B - - - 11 B - - - 9.3 B - - - 8.06 B - - - 7.87 B - - - 7.34 B - - - 7.17 B - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

557 M 619 M 302 M - - - - 1.28 B - - - 1.75 B - - - 257 M - - - 333 M - - - 155 M - - - 38 M - - - 102 M - - - 65 M - - - - - - - - - - - - - - -

Book Value

5.29 B 5.26 B 5.22 B - - - - 5.57 B - - - 5.28 B - - - 5.14 B - - - 4.87 B - - - 4.64 B - - - 3.96 B - - - 3.97 B - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

5.29 B 5.26 B 5.22 B - - - - 5.57 B - - - 5.28 B - - - 5.14 B - - - 4.87 B - - - 4.64 B - - - 3.96 B - - - 3.97 B - - - 4.04 B - - - - - - - - - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Smith & Nephew plc, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
- 0.28 % $ 270 M usaUSA
AxoGen AxoGen
AXGN
$ 48.28 2.51 % $ 2.22 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 58.5 0.13 % $ 8.88 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 74.29 2.75 % $ 2.2 B costa-ricaCosta-rica
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Abiomed Abiomed
ABMD
- - $ 17.2 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 108.33 0.19 % $ 189 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 1.82 6.04 % $ 1.23 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 6.49 1.09 % $ 877 M usaUSA
Align Technology Align Technology
ALGN
$ 158.64 0.03 % $ 11.5 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.05 0.32 % $ 125 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.27 0.3 % $ 33.1 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 9.45 1.29 % $ 1.42 B usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 7.36 0.96 % $ 1.82 B usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 386.11 0.05 % $ 10.5 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 47.8 1.83 % $ 70.8 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.47 0.71 % $ 618 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 13.96 0.67 % $ 395 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 49.32 0.02 % $ 1.53 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.35 0.03 % $ 21.8 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 16.48 1.1 % $ 590 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA